Rani Therapeutics Holdings, Inc.RANINASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-3579.08%
↓ 52% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
-2360.19%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -3579.08% | +27.2% |
| 2024 | -4914.69% | - |
| 2023 | 0.00% | - |
| 2022 | 0.00% | +100.0% |
| 2021 | -1916.97% | +44.5% |
| 2020 | -3453.46% | -30.0% |
| 2019 | -2657.10% | - |